Last reviewed · How we verify

NCT06628479

Relaxin, Matrix Metalloproteinase-2 and Interleukin-6 in Women With Chronic Pelvic Pain

Completed Last updated 8 October 2024
What this trial tests

trial testing interleukin, enzyme, hormone in Endometriosis in 60 participants. Completed in 15 June 2023.

Timeline
15 June 2022
Primary endpoint
15 January 2023
15 June 2023

Quick facts

Lead sponsorSanliurfa Mehmet Akif Inan Education and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date15 June 2022
Primary completion15 January 2023
Estimated completion15 June 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sanliurfa Mehmet Akif Inan Education and Research Hospital

Who can join

Adults 35 to 72, female only, with Endometriosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In our study, by evaluating the serum and vaginal-peritoneal fluid levels of Relaxin, Matrix Metalloproteinase-2 and Interleukin-6 in women over 35 years of age with chronic pelvic pain, the investigators aimed to reveal their potential to be an important marker in the diagnosis of Deep Infiltrative Endometriosis, thus enabling early diagnosis with lower cost and results that can be obtained in a short time.The investigators aim to reveal its relationship with follow-up. In our study, the values of Relaxin, MMP-2 or IL-6 from vaginal fluids were found to be significantly higher than the control group in the prediction and follow-up of deep infiltrative endometriosis. This supports the role of Relaxin and MMP-2 as well as IL-6 in the pathophysiology of deep infiltrative endometriosis. Histologically based and multicenter randomized controlled studies with more patients are needed to elucidate the etiology and pathophysiology of endometriosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

Other Sanliurfa Mehmet Akif Inan Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06628479.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing